This website is intended for UK healthcare professionals only Log in | Register

News and views

November 2002 Br J Cardiol 2002;9:590-2

Revascularisation and the diabetic patient: the potential role of drug-eluting stents

Revascularisation and the diabetic patient: the potential role of drug-eluting stents David Barrow David Barrow, a medical journalist with a special interest in interventional cardiology, discusses the potential benefit of drug-eluting stents in relationship to the revascularisation of the diabetic patient. It has been estimated that 13% to 25% of the patients undergoing coronary revas-cularisation procedures have diabetes and the diabetic patient continues to face higher mortality rates than non-diabetic patients after revascularisation. There is much debate on the preferred method of revascularisation in the diabetic patient: percutaneous transluminal intervention (PCI) or coronary artery bypass graft surgery (CABG)....

September 2002 Br J Cardiol 2002;9:491-2

Waiting for a bypass: a comment from primary care

Waiting for a bypass: a comment from primary care Peter Stott The length of time that patients spend on the waiting list for coronary artery bypass surgery (CABG) is a matter of concern. In one study of 1,049 patients in the South East of the UK, the mean time to specialist consultation was 36 days (SD 43); the time waiting for coronary angiography was 85 days (SD 89); and the mean time on the surgical waiting list for CABG was 133 days (SD 134) – a mean time of 279 days (SD 209; range 1–1,579 days) from GP referral1 to CABG....

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now